NEW YORK CITY — Dr. Tonia Rex, associate professor of ophthalmology at Vanderbilt University School of Medicine, presented on mechanisms and therapy for optic nerve trauma during SUNY Optometry’s Schnurmacher Institute for Vision Research colloquium on Friday, September 14.Dr. Rex studies mechanisms underlying vision loss in ocular trauma and glaucoma and tests the efficacy of neuroprotective therapies. Her laboratory has identified a novel mutation in erythropoietin (EPO) that retains EPO’s neuroprotective activity while attenuating production of red blood cells and explores how EPO-R76E prevented degeneration in glaucoma.
She earned her bachelor’s degree in biochemistry from Oakland University and her doctorate in molecular, cellular and developmental biology at the University of California, Santa Barbara. She was also post-doctoral fellow at the University of Pennsylvania where she studied retinal gene therapy prior to joining the Vanderbilt faculty.
About the Schnurmacher Institute for Vision Research at SUNY Optometry
The Institute for Vision Research was founded in 1983 in response to the growing need for scientific knowledge about the visual system and methods of improving visual function. The Institute was renamed the Adolph and Ruth Schnurmacher Institute for Vision Research (SIVR) in 1984 to honor the Schnurmacher’s generosity that made possible the establishment of an Institutional endowment. The scientific researchers associated with the Institute are engaged in a wide variety of vision research projects. The SIVR coordinates a colloquium series and supports collaborative clinical research, small clinical research projects and innovative vision science research.